Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.

In, Haejin

Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy. [electronic resource] - Annals of surgical oncology 06 2016 - 1956-62 p. digital

Publication Type: Journal Article

1534-4681

10.1245/s10434-015-5075-1 doi


Adenocarcinoma--drug therapy
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Chemoradiotherapy, Adjuvant--mortality
Combined Modality Therapy
Female
Follow-Up Studies
Gastrectomy--mortality
Humans
Lymph Node Excision--mortality
Lymph Nodes--pathology
Male
Middle Aged
Neoadjuvant Therapy--mortality
Prognosis
Retrospective Studies
Stomach Neoplasms--drug therapy
Survival Rate